E-drug: Cost effectiveness in Drug Registration (cont'd)
-------------------------------------------------------------------------
Hi,
The situation in New Zealand is similar to that in Australia: cost
effectiveness is not a criterion for registration, but it is important in
deciding whether a medicine will be subsidised by the government,
(through Pharmac www.pharmac.govt.nz). Until recently, there
hasn't been much of a market for prescription medicines that are
not subsidised.
Pauline
Pauline Norris
Senior Research Fellow
Health Services Research Centre
Victoria University
P.O.Box 600
Wellington
New Zealand
ph (04) 463 6571 (direct dial)
(04) 463 6565
fax (04) 463 6568
e-mail: pauline.norris@vuw.ac.nz
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.